The median serum GDF15 concentration in untreated patients with MADD was 7045 pg/mL, significantly higher than that in patients with MDs (2384 pg/mL), and healthy controls (374 pg/mL) (Fig. 1A). The gene discussed is GDF15; the disease is myelodysplastic syndrome.